Erythrocyte phosphatidylserine exposure in β-thalassemia

Laboratory Hematology

Volumn 20, Issue 2, 2014, Pages 9-14

  Ibrahim, Hamdy A ^a   Fouda, Manal I ^b   Yahya, Raida S ^c   Abousamra, Nashwa Khairat ^b   Abd Elazim, Rania A ^c  

^a Mansoura University   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

Author keywords

Annexin V; Flow cytometry; Phosphatidylserine; RBCs; Thalassemia

Indexed keywords

FERRITIN; HEMOGLOBIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BETA THALASSEMIA MAJOR; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; SPLENECTOMY; THALASSEMIA MAJOR; CLINICAL TRIAL; ERYTHROCYTE MEMBRANE; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE MEMBRANE; FEMALE; FERRITINS; HUMANS; MALE; PHOSPHATIDYLSERINES;

EID: 84904285653     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.12016     Document Type: Article

References (31)

1. Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009; 80:339-344.
2. Thein SL. Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol. 2004;124:264-274. (Pubitemid 38167976)
3. Leung TN, Lau TK, Chung TKh. Thalassaemia screening in pregnancy. Curr Opin Obstet Gynecol. 2005;17:129-134. (Pubitemid 40432732)
4. Lukens JN. The thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, ed. Wintrobe's Clinical Hematology. Baltimore, MD, Williams and Wilkins; 1999:1405.
5. Finch CA, Deubelbeiss K, Cook JD, et al. Ferrokinetics in man. Medicine. 1970 49:17-53.
6. Schrier SL, Rachmilewitz EA, Mohandas N. Cellular and membrane properties of alpha and beta thalassemia erythrocytes are different: implication for differences in clinical manifestations. Blood. 1989;74:2194-2202. (Pubitemid 19269130)
7. Shinar E, Rachmilewitz EA. Haemoglobinopathies and red cell membrane function. Baillieres Clin Haematol. 1993;2:357-369. (Pubitemid 23204994)
8. Schrier SL. Thalassemia: pathophysiology of red cell changes. Annu Rev Med. 1994;45:211-218. (Pubitemid 24158157)
9. Schrier SL. Pathophysiology of thalassemia. Curr Opin Hematol . 2002;9:123-126. (Pubitemid 34171488)
10. Wagner GM, Chiu DT, Yee MC, Lubin BH. Red cell vesiculation-a common membrane physiologic event. J Lab Clin Med . 1986;108:315-324. (Pubitemid 16003238)
11. Shinar E, Shalev O, Rachmilewitz EA, Schrier SL. Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia. Blood. 1987;70:158-164. (Pubitemid 17111256)
12. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol . 1993;44:63-65.
13. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood . 1997; 89:1121-1132. (Pubitemid 27079974)
14. Kuypers FA, Yuan J, Lewis RA, et al. Membrane phospholipid asymmetry in human thalassemia. Blood. 1998;91:3044-3051. (Pubitemid 28227558)
15. Pattanapanyasat K, Noulsri E, Fucharoen S, Lerdwana S, Lamchiagdhase P, Siritanaratkul N, Webster HK. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom. 2004;57:23-31 (Pubitemid 38297620)
16. Shinar E, Rachmilewitz EA, Lux SE. Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. J Clin Invest. 1989; 83:404-410. (Pubitemid 19061158)
17. Kuypers FA, de Jong K. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol. 2004;50:147-158.
18. Föller M, Huber SM, Lang F. Erythrocyte programmed cell death. IUBMB Life. 2008;60:661-668.
19. Connor J, Pak CC, Schroit AJ. Exposure of phosphatidylserine in the outer leaflet of human red blood cells. Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem. 1994;269:2399-2404.
20. Schlegel RA, Williamson P. Phosphatidylserine, a death knell. Cell Death Differ. 2001;8:551-563. (Pubitemid 32586592)
21. Ernst JD. Epitope mapping of annexin I: antibodies that compete with phospholipids and calcium recognize amino acids 42-99. Biochem J. 1993;289:539-542. (Pubitemid 23042066)
22. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta . 1994;197:63-93.
23. Chasis JA, Mohandas N. Red blood cell glycophorins. Blood . 1992;80:1869-1879.
24. Catimel B, Wilson KM, Kemp BE. Kinetics of the autologous red cell agglutination test. J Immunol Methods. 1993;165:183-192.
25. Setty BN, Kulkarni S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood 2000;96:1119-1124. (Pubitemid 30616882)
26. Willekens FL, Werre JM, Groenen-Döpp YA, Roerdinkholder- Stoelwinder B, de Pauw B, Bosman GJ. Erythrocyte vesiculation: a self-protective mechanism? Br J Haematol . 2008;141:549-556. (Pubitemid 351550554)
27. Hegazy L, Kamal S, Ahmed A, Saad NE, El Desouki N, Abd El-Azim K. Flow cytometric determination of percentage of red blood vesicles in β-thalassemia. J Med Sci. 2008;8:182-187.
28. Ikram N, Hassan K, Younas M, Amanat S. Ferritin levels in patients of beta thalassaemia major. Int J Pathol. 2004;2:71-74.
29. Giardina PJ, Grady RW. Chelation therapy in β-thalassemia; an optimistic update. Haematol. 2001;38:360-366. (Pubitemid 32995605)
30. Lamchiagdhase P, Nitipongwanich R, Rattanapong C, Noulsri E, Lerdwana S, Pattanapanyasat K. Red blood cell vesicles in thalassemia. J Med Assoc Thai. 2004;87:233-238. (Pubitemid 38715216)
31. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Polonifi A, Moyssakis I, Diamanti-Kandaraki E, Papalambros E. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia. Ann Hematol. 2005;84:353-3572